Skip to content
  • Home
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Latest News
  • Business
  • Finance
  • Contact Us

Search

  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Contact
亚洲新闻、事件、深度報道

ba.1、ba.2和ba.4/ba.5变体以及原始野生型等病毒株均可产生强烈的中和抗体反应。复必泰二价疫苗针对现时主流变异株omicron

ACN Newswire

针对现时主流变异株Omicron BA.4-5复必泰二价新冠疫苗已运抵港澳并即将开打

tallulah 28 November
1 minute

HONG KONG, Nov 28, 2022 – (亚太商讯 via SEAPRWire.com) – 针对新冠病毒奥密克戎Omicron变异株BA.4-5的复必泰二价mRNA疫苗已于11月25日运抵港澳。同日,供...

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    

网站导航

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us

Search

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us
Copyright © 2020 ASEANPR.Com All rights reserved.